TLSI TriSalus Life Sciences, Inc.companySEC Filings & Insider Trading Activity 2026
Latest TriSalus Life Sciences, Inc. (TLSI) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 5, 2026, a 10-Q quarterly report filed on November 13, 2025, an 8-K current report filed on April 29, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for TriSalus Life Sciences, Inc. (TLSI) (SEC CIK 1826667), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 2.02: Results of Operations and Financial Condition
- • Q4 and full-year 2025 financial results announced March 5, 2026 — details in Exhibit 99.1
- • Filing furnished, not "filed" — limits legal liability under Exchange Act Section 18
Recent 8-K FilingsCurrent Reports
AI-powered analysis of TriSalus Life Sciences, Inc. (TLSI) 8-K current reports disclosing material events.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 29, 2026 | — | — | — |
8-K | Apr 7, 2026 | — | — | — |
10-K | Mar 5, 2026 | Dec 31, 2025 | — | |
8-K | Mar 5, 2026 | — | Analysis | — |
8-K | Feb 20, 2026 | — | — | |
8-K | Feb 9, 2026 | — | — | |
8-K | Jan 12, 2026 | — | — | |
10-Q | Nov 13, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 12, 2025 | Jun 30, 2025 | — | |
10-Q | May 15, 2025 | Mar 31, 2025 | — | |
10-K | Apr 15, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 14, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 14, 2024 | Jun 30, 2024 | — | |
10-Q | May 15, 2024 | Mar 31, 2024 | — | |
10-K | Apr 11, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 14, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 2, 2023 | Jun 30, 2023 | — | |
10-Q | May 12, 2023 | Mar 31, 2023 | — | |
10-K | Mar 22, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 10, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 10, 2022 | Jun 30, 2022 | — | |
10-Q | May 11, 2022 | Mar 31, 2022 | — | |
10-K | Mar 3, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 12, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 16, 2021 | Jun 30, 2021 | — |
Frequently Asked Questions
What are the latest TLSI SEC filings in 2026?
TriSalus Life Sciences, Inc. (TLSI) has filed a 10-K annual report on March 5, 2026, a 10-Q quarterly report on November 13, 2025, an 8-K current report on April 29, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did TLSI file its most recent 10-K annual report?
TriSalus Life Sciences, Inc. (TLSI) filed its most recent 10-K annual report on March 5, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view TLSI 10-Q quarterly reports?
TriSalus Life Sciences, Inc. (TLSI)'s most recent 10-Q quarterly report was filed on November 13, 2025. SignalX displays every TLSI 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has TLSI filed recently?
TriSalus Life Sciences, Inc. (TLSI)'s most recent 8-K was filed on April 29, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find TLSI insider trading activity (Form 4)?
SignalX aggregates every TLSI Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does TLSI file with the SEC?
TriSalus Life Sciences, Inc. (TLSI) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new TLSI filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for TriSalus Life Sciences, Inc. (TLSI).
What is TLSI's SEC CIK number?
TriSalus Life Sciences, Inc. (TLSI)'s SEC CIK (Central Index Key) number is 1826667. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1826667 to look up all TLSI filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find TLSI return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from TriSalus Life Sciences, Inc. (TLSI) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of TriSalus Life Sciences, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 27+ filings.